Learning Objectives:

Discuss the population health impact of postoperative delirium.
Review plausible biological mechanisms and biomarkers.
Introduce the minimizing ICU neurological dysfunction with dexmedetomidine induced sleep trial.

Faculty/Planning Committee:

Oluwaseun Johnson-Akeju, MD, Presenter, has no relevant financial relationships to disclose.

Faculty member does not plan on discussing unlabeled/investigational uses of a commercial product.